Perfecting the Formula for Oligonucleotide Drugs: Rational Use of Chemical Modifications

Time: 2:00 pm
day: Day One PM


• Evaluating strategies in chemical modification to improve stability and potency of oligonucleotides in CNS the aim to deliver infrequent dosing and avoid repeated intrathecal administration

• Reviewing considerations in antisense chemistry to guide best decision making for each therapeutic